Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) filed a Form 8-K with the Securities and Exchange Commission on January 09, 2026, disclosing a material event.
Zentalis Pharmaceuticals, Inc.'s stock currently trades at $0.00 with a market capitalization of $0. The company's stock moved following the disclosure.